ARCHIVES

Study Section Members Likelier to Be Funded

This article is from The Cancer Letter archive.

Vol. 12 No. 31 | August 1, 1986

Download PDF Visit The Full Archive

Related Articles

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

NIH Workshop On Animal Care Planned

May 4, 1990

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976